吡格列酮联合克罗米芬治疗多囊卵巢综合征临床效果分析  

Clinical effectiveness analysis of pioglitazone and clomiphene treatment of polycystic ovary syndrome

作　　者：葛淑琦[1] 陶欣[1] 

机构地区：[1]中山大学附属第三医院不育与性医学科,广东广州510630

出　　处：《中外女性健康研究》2016年第13期7-8,共2页Women＇s Health Research

摘　　要：目的:对多囊卵巢综合征患者行吡格列酮联合克罗米芬疗法的临床效果进行分析。方法:选取我院2015年4月1日至2016年4月1日收治的多囊卵巢综合征患者共计60例作为研究对象,将其按照随机数字表法均分为实验组与对照组,各30例。对对照组行克罗米芬疗法,对实验组行吡格列酮联合克罗米芬疗法,比较两组患者的临床疗效、胰岛素水平以及不良反应发生情况。结果:实验组患者的临床疗效、胰岛素水平以及不良反应发生情况均显著性优于对照组,差异显著,存在统计学意义(P<0.05)。结论:对多囊卵巢综合征患者行吡格列酮联合克罗米芬疗法的临床效果比较显著,可有效改善患者的胰岛素水平,显著降低患者的不良反应发生情况,具有临床应用价值。Purpose：In order to analyze pioglitazone and clomiphene treatment of patients with polycystic ovary syndrome.Methods：Choose 60 patients with polycystic ovary syndrome who were treated in our hospital in April 1,2015 to April 1,2016.They were divided into test group and control group randomly,each group of 30 patients.The control group patients were treated with clomiphene therapy and test group patients with pioglitazone and clomiphene therapy to compare the clinical effectiveness,Insulin levels and adverse reactions between the two groups.Result：the clinical effectiveness,Insulin levels and adverse reactions of test group patients are better than the control group＇s.The difference is of statistical significance（P〈0.05）.Conclusion：clinical effectiveness of pioglitazone and clomiphene therapy is evident,it can effectively improve the patient＇s insulin levels and reduce the incidence of adverse reactions.It has the clinical value.

关 键 词：多囊卵巢综合征 吡格列酮 克罗米芬 临床效果 

分 类 号：R711.7[医药卫生—妇产科学]